Target intelligence / Profile preview

WD repeat-containing protein 82 (WDR82)

Target
WDR82
Molecular classification
Epigenetic regulator, Histone modification complex component, Scaffold protein, WD40-repeat protein
01

Overview

WD repeat-containing protein 82 (WDR82) is a nuclear scaffold protein with seven WD40 domains that acts primarily as a regulatory component of the SET1/COMPASS histone H3K4 methyltransferase complex, facilitating the recruitment of SETD1A or SETD1B to the phosphorylated C-terminal domain of RNA polymerase II at transcriptional start sites, enabling proper gene activation through H3K4 trimethylation[2][3][5]. WDR82 is also a component of the PNUTS-PP1 phosphatase complex, contributing to chromatin structure regulation and cell cycle progression[3][5]. It is essential for normal embryonic development, pluripotency maintenance, transcriptional regulation, and metabolic pathway modulation during somatic cell reprogramming[1][2][3]. Loss of WDR82 disrupts normal histone methylation and impairs proliferation and differentiation, and rare genetic defects in WDR82 are associated with specific neurodevelopmental and skeletal disorders[3][5]. There is no evidence to date that WDR82 is a direct target for therapeutic small molecules or biologic drugs.

Other names
SWD2TMEM113WDR82AMST107MSTP107PRO2730PRO34047hWDR82WDR82p
02

Biological functions

Regulation of histone H3K4 trimethylationRecruitment of the SET1 (Setd1A/B) complex to transcription start sitesRegulation of gene transcriptionControl of chromatin structureCell cycle progression (particularly mitosis–interphase transition)Pluripotency maintenance in embryonic stem cellsRegulation of cellular energy metabolism
03

Disease associations

Neurodevelopmental disorder with speech impairment and dysmorphic faciesEmbryonic developmental defectsOmodysplasia 1
04

Safety considerations

There are currently no specific safety concerns or therapeutic challenges reported regarding WDR82 as a direct therapeutic target. Loss of WDR82 function leads to reduced histone H3K4 trimethylation and defects in cell growth and gene expression[1][2][3].

Beyond the preview

Go deeper on WD repeat-containing protein 82 (WDR82).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat-containing protein 82 (WDR82).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call